Clinical Trial Update: Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of dialysate containing soluble iron for treating end-stage renal disease patients on chronic hemodialysis has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Dialysate containing soluble iron

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End-Stage Renal Disease (ESRD) | Phase 2 | Status: COMPLETED | Results posted: 2011-02-08